Early Stage Venture Ori Biotech Raises Series A of $30000000

October 13, 2020

About Ori Biotech

Ori Biotech is a developer of a manufacturing platform used to help patients get access to lifesaving treatments.

Website: Learn more on Ori Biotech’s website

Crunchbase: Follow on Crunchbase

[adace-ad id=”4426″]

Series A – Ori Biotech

Amount Raised30000000 USD
Announced Date2020-10-14
Equity Only FundingYes
Organization LocationLondon, England, United Kingdom, Europe
Funding StatusEarly Stage Venture
Number of Funding Rounds2
Lead InvestorsNorthpond Ventures
Number of Investors5
Number of Partner Investors1
Previous Story

Early Stage Venture Sanity Raises Series A of $9300000

Next Story

Early Stage Venture Blubrake Raises Series A of $6106870